Lisa Detering Selected Research

vMIP-II

1/2021	CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis.
1/2016	PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa Detering Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 01/2014
9	Atherosclerosis 01/2021 - 04/2014
4	Disease Progression 01/2021 - 04/2014
2	Triple Negative Breast Neoplasms 01/2019 - 03/2016
2	Atherosclerotic Plaque (Atheroma) 10/2016 - 01/2015
2	Neoplasm Metastasis (Metastasis) 04/2016 - 01/2016
2	Vascular System Injuries 01/2016 - 04/2014
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Adenocarcinoma 01/2021
1	Brain Neoplasms (Brain Tumor) 11/2020
1	Diffuse Intrinsic Pontine Glioma 11/2020
1	Abdominal Aortic Aneurysm 01/2020
1	Inflammation (Inflammations) 01/2020
1	Rupture 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Myocardial Infarction 01/2019
1	Skin Neoplasms (Skin Cancer) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 11/2014

Drug/Important Bio-Agent (IBA)

7	GoldIBA 01/2022 - 01/2014
6	Apolipoproteins E (ApoE)IBA 01/2021 - 04/2014
6	Chemokine ReceptorsIBA 01/2021 - 04/2014
5	Peptides (Polypeptides)IBA 01/2021 - 01/2015
5	ApolipoproteinsIBA 01/2021 - 04/2014
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2014
3	ChemokinesIBA 01/2021 - 04/2014
3	CopperIBA 01/2021 - 06/2019
3	Tumor Biomarkers (Tumor Markers)IBA 06/2019 - 04/2016
3	Natriuretic PeptidesIBA 05/2019 - 07/2016
2	Pharmaceutical PreparationsIBA 01/2022 - 06/2019
2	CCR5 Receptors (CCR5 Receptor)IBA 01/2021 - 04/2014
2	vMIP-IIIBA 01/2021 - 01/2016
2	Radioisotopes (Radionuclides)IBA 04/2016 - 01/2015
2	AmidesIBA 04/2016 - 03/2016
2	CC ChemokinesIBA 04/2016 - 03/2016
1	CXC ChemokinesIBA 01/2022
1	(64)Cu-DOTA-vMIP-IIIBA 01/2021
1	CCR ReceptorsIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	dipinacoline glutamateIBA 11/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2020
1	AminopropionitrileIBA 01/2020
1	EpitopesIBA 05/2019
1	Atrial Natriuretic Factor (ANF)IBA 05/2019
1	Diphtheria ToxinIBA 01/2019
1	Zirconium-89IBA 01/2019
1	mirvetuximab soravtansineIBA 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2018
1	MelanocortinsIBA 01/2018
1	Type 1 Melanocortin ReceptorIBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2016
1	D-Ala-peptide T-amideIBA 03/2016
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2016
1	Polymethyl Methacrylate (Sol)IBA 01/2016
1	plerixafor FDA Link 01/2016
1	AntibodiesIBA 01/2015
1	AlloysIBA 11/2014

Therapy/Procedure

5	Therapeutics 01/2022 - 03/2016
3	Precision Medicine 06/2019 - 03/2016